Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells

Published:2015-09-26 Issue:1 Volume:13 Page:
ISSN:1477-3155
Container-title:Journal of Nanobiotechnology
language:en
Short-container-title:J Nanobiotechnol

Author:

Kwak Tae Won,Kim Do Hyung,Jeong Young-Il,Kang Dae Hwan

Funder

Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Link

http://link.springer.com/content/pdf/10.1186/s12951-015-0122-4

Reference50 articles.

1. Richon VM. Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilidehydroxamic acid), a novel histone deacetylase inhibitor. Br J Cancer. 2006;95:S2–6.

2. Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB. Suberoylanilidehydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J Biol Chem. 2006;281:5612–22.

3. Doi T, Hamaguchi T, Shirao K, Chin K, Hatake K, Noguchi K, et al. Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial. Int J Clin Oncol. 2013;18:87–95.

4. Claerhout S, Lim JY, Choi W, Park YY, Kim K, Kim SB, et al. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer. PLoS One. 2011;6:e24662.

5. Jin JS, Tsao TY, Sun PC, Yu CP, Tzao C. SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Pathol Oncol Res. 2012;18:713–20.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

2. Development of New Nanoniosome Carriers for Vorinostat: Evaluation of Anticancer Efficacy In Vitro;Journal of Pharmaceutical Sciences;2024-08

3. Stochasticity of anticancer mechanisms underlying clinical effectiveness of vorinostat;Heliyon;2024-06

4. Tannins in cancer prevention and therapy;British Journal of Pharmacology;2023-10-03

5. Nanoparticle-mediated therapeutic management in cholangiocarcinoma drug targeting: Current progress and future prospects;Biomedicine & Pharmacotherapy;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3